Zoetis ZTS
NYSE ZTS
$69.68 +0.56 (+0.81%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zoetis (ZTS) Non Operating Investment Income (2016)

Updated

Zoetis' Non Operating Investment Income came in at -$3 million for FY2025, compared with -$23 million in FY2024.

Analysis

Zoetis (ZTS) Non Operating Investment Income (2016) Analysis & Trends

  • Per Business Quant, earlier years put Non Operating Investment Income at -$23 million in FY2024 and $101 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Zoetis 28.86 Bn 20.71 Bn 1.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Apr 3, 2016 33.00 Mn
API Access

Zoetis Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ZTS&period=max&api_key=YOUR_API_KEY